PortfoliosLab logo
Raia Drogasil SA ADR (RADLY)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US7507231089

Highlights

Market Cap

$5.02B

EPS (TTM)

$0.13

PE Ratio

22.54

Total Revenue (TTM)

$39.81B

Gross Profit (TTM)

$11.33B

EBITDA (TTM)

$3.56B

Year Range

$2.42 - $7.34

Target Price

$6.60

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Raia Drogasil SA ADR

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Raia Drogasil SA ADR (RADLY) returned -22.57% year-to-date (YTD) and -44.01% over the past 12 months.


RADLY

YTD

-22.57%

1M

-21.88%

6M

-35.20%

1Y

-44.01%

3Y*

-12.67%

5Y*

-6.54%

10Y*

N/A

^GSPC (Benchmark)

YTD

0.52%

1M

6.32%

6M

-1.44%

1Y

12.25%

3Y*

12.45%

5Y*

14.20%

10Y*

10.84%

*Annualized

Monthly Returns

The table below presents the monthly returns of RADLY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20252.87%-19.27%13.02%4.90%-21.35%-22.57%
2024-12.72%22.96%-15.47%-9.13%-3.39%-3.66%6.20%-0.96%-3.29%-9.74%-5.23%-10.79%-40.44%
20237.91%-11.34%10.72%9.61%7.25%4.60%4.02%-8.17%-1.80%-7.05%11.51%6.59%34.96%
2022-6.95%15.81%-7.64%-2.55%1.42%-14.07%-1.50%21.26%-4.10%8.07%-3.47%4.24%5.29%
2021-5.39%-0.59%-1.08%-0.14%17.70%-6.04%-0.59%1.61%-14.52%-5.13%0.13%8.41%-8.64%
20207.65%-9.58%-25.44%-0.13%4.30%0.31%18.64%-17.92%7.51%-1.64%15.55%-0.23%-9.97%
201913.70%5.96%-4.58%2.66%-3.69%19.70%9.79%-3.14%8.49%17.85%-1.74%1.08%83.74%
2018-3.67%-10.03%-6.25%-12.21%-16.16%3.07%17.81%-3.94%-3.91%-8.13%-5.36%-7.77%-46.25%
201710.52%-8.11%-2.48%11.09%7.57%-3.00%1.03%2.65%3.31%4.54%12.08%2.95%48.38%
2016-4.11%-3.12%12.16%9.84%-16.09%0.08%-3.88%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RADLY is 21, meaning it’s performing worse than 79% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RADLY is 2121
Overall Rank
The Sharpe Ratio Rank of RADLY is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of RADLY is 2222
Sortino Ratio Rank
The Omega Ratio Rank of RADLY is 2020
Omega Ratio Rank
The Calmar Ratio Rank of RADLY is 1717
Calmar Ratio Rank
The Martin Ratio Rank of RADLY is 2525
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Raia Drogasil SA ADR (RADLY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Raia Drogasil SA ADR Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: -0.55
  • 5-Year: -0.07
  • All Time: -0.04

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Raia Drogasil SA ADR compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Raia Drogasil SA ADR provided a 2.42% dividend yield over the last twelve months, with an annual payout of $0.07 per share.


0.40%0.60%0.80%1.00%1.20%1.40%1.60%$0.00$0.02$0.04$0.06$0.08201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM202420232022202120202019201820172016
Dividend$0.07$0.05$0.07$0.05$0.04$0.02$0.03$0.03$0.04$0.03

Dividend yield

2.42%1.51%1.18%1.10%0.94%0.43%0.53%1.11%0.64%0.74%

Monthly Dividends

The table displays the monthly dividend distributions for Raia Drogasil SA ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.01$0.01$0.02
2024$0.00$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.00$0.02$0.00$0.01$0.05
2023$0.00$0.00$0.00$0.02$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.03$0.07
2022$0.00$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.00$0.02$0.00$0.01$0.05
2021$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.02$0.01$0.04
2020$0.00$0.00$0.00$0.01$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.01$0.02
2019$0.00$0.00$0.01$0.00$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.01$0.03
2018$0.00$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.01$0.03
2017$0.00$0.00$0.01$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.01$0.01$0.04
2016$0.02$0.00$0.00$0.01$0.03

Dividend Yield & Payout


Dividend Yield

Raia Drogasil SA ADR has a dividend yield of 2.42%, which is quite average when compared to the overall market.

Payout Ratio

Raia Drogasil SA ADR has a payout ratio of 47.19%, which is quite average when compared to the overall market. This suggests that Raia Drogasil SA ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Raia Drogasil SA ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Raia Drogasil SA ADR was 81.91%, occurring on May 16, 2025. The portfolio has not yet recovered.

The current Raia Drogasil SA ADR drawdown is 79.52%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.91%Feb 27, 2023457May 16, 2025
-48.37%Sep 30, 2020264Jul 6, 202260Feb 24, 2023324
-46.7%Nov 30, 2017182Dec 26, 201898Nov 4, 2019280
-41.46%Jan 31, 202045May 15, 202066Sep 28, 2020111
-20.33%Nov 1, 20166Dec 13, 201638Jun 2, 201744
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Raia Drogasil SA ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Raia Drogasil SA ADR, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -32.8%.


0.010.020.030.0420212022202320242025
0.02
0.03
Actual
Estimate

Valuation

The Valuation section provides an overview of how Raia Drogasil SA ADR is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for RADLY, comparing it with other companies in the Pharmaceutical Retailers industry. Currently, RADLY has a P/E ratio of 22.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RADLY relative to other companies in the Pharmaceutical Retailers industry. Currently, RADLY has a P/S ratio of 0.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for RADLY in comparison with other companies in the Pharmaceutical Retailers industry. Currently, RADLY has a P/B value of 4.4. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items